News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alimera Sciences (ALIM) Prices Low IPO


4/22/2010 7:17:12 AM

Pehub.com -- Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, raised around $72 million in its IPO. The company sold 6.5 million common shares at $11 per share, compared to original plans to sell 6 million shares bat between $15 and $17 per share.

Read at Private Equity Hub
Read at AP


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES